PHISODERM  CLEAN ANTI-BLEMISH FACIAL CLEANSER- salicylic acid gel 
The Mentholatum Company

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product

  • avoid contact with eyes. If contact occurs, flush thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

water, lauramidopropyl betaine, sodium C14-16 olefin sulfonate, lauryl glucoside, aloe barbadensis leaf juice, aminomethyl propanol, butylene glycol, caprylyl/capryl glucoside, carica papaya (papaya) fruit extract, chamomilla recutita (matricaria) flower extract, disodium EDTA, fragrance, glycerin, hydroxyphenyl propamidobenzoic acid, hydroxypropyltrimonium hyaluronate, pentylene glycol, potassium sorbate, sodium benzoate, sodium chloride, tocopheryl acetate [vitamin E]

Questions?

1-877-636-2677 MON-FRI 9 AM to 5 PM (EST)

Principal Display Panel

pHisoderm CLEAN ANTI-BLEMISH FACIAL CLEANSER

Principal Display Panel

Drug Facts
PHISODERM   CLEAN ANTI-BLEMISH FACIAL CLEANSER
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10742-1235
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
LAURAMIDOPROPYL BETAINE (UNII: 23D6XVI233)  
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
LAURYL GLUCOSIDE (UNII: 76LN7P7UCU)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
CAPRYLYL/CAPRYL OLIGOGLUCOSIDE (UNII: E00JL9G9K0)  
PAPAYA (UNII: KU94FIY6JB)  
CHAMOMILE (UNII: FGL3685T2X)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
HYDROXYPHENYL PROPAMIDOBENZOIC ACID (UNII: 25KRT26H77)  
DIHYDROXYPROPYLTRIMONIUM (UNII: 925G44QFFO)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10742-1235-1177 mL in 1 BOTTLE; Type 0: Not a Combination Product07/02/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D07/02/2021
Labeler - The Mentholatum Company (002105757)
Registrant - The Mentholatum Company (002105757)
Establishment
NameAddressID/FEIBusiness Operations
The Mentholatum Company002105757manufacture(10742-1235)

Revised: 2/2023
Document Id: f42125d5-b3ef-1cc9-e053-2995a90abb44
Set id: d2799f22-5684-4510-9141-073acf4b1534
Version: 2
Effective Time: 20230207
 
The Mentholatum Company